Credit: Getty Images |
In a small but rigorous pilot study, Johns Hopkins Medicine researchers have shown that a novel, minimally invasive biomarker-based strategy they developed was 90% successful in detecting esophageal squamous cell carcinoma (ESCC), the predominant subtype of esophageal cancer worldwide.
Although less common than some other tumor types in the United States, esophageal cancer remains the sixth-most common cause of cancer death worldwide, claiming the lives of more than half
